New study tracks Real-World use of acromegaly drug over two years
Disease control
Not yet recruiting
This study follows 200 people with acromegaly who are starting or already using octreotide subcutaneous depot. Researchers will track side effects and how well the drug controls hormone levels and symptoms for up to two years in everyday medical practice. The goal is to see if th…
Sponsor: Camurus AB • Aim: Disease control
Last updated May 17, 2026 09:01 UTC